help button home button Am J Pathol ASIP WHAT IS IT?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anderson, R. E.
Right arrow Articles by Troup, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anderson, R. E.
Right arrow Articles by Troup, G. M.

American Journal of Pathology, Vol 109, 169-178, Copyright © 1982 by American Society for Investigative Pathology


REGULAR ARTICLES

Effects of irradiation upon the response of murine spleen cells to mitogens

RE Anderson and GM Troup

The mitogenic response of murine spleen cells exposed to graded doses of radiation was evaluated. Low-dose exposures were associated with an augmented response to concanavalin A (Con A) that was most marked with 100 rads. Low-dose augmentation of phytohemagglutinin (PHA) stimulation was equivocal and most pronounced in cells exposed to 10-20 rads. Augmentation was only demonstrable when the cells were irradiated immediately prior to mitogenic stimulation. Timed exposures after stimulation with Con A or PHA showed no evidence that mitogen activation increased radioresistance, although the possibility could not be excluded that activation protects against interphase cell death. Reduced isotope incorporation was associated with all doses of radiation evaluated in cells stimulated with lipopolysaccharide (LPS) or pokeweed mitogen (PWM). On this basis it is concluded that 1) each of the mitogens tested differs in its capacity to stimulate irradiated spleen cells; 2) radiation-induced augmentation is noted with those mitogens (Con A and possibly PHA) known to activate only T cells; 3) radiation-induced augmentation may be due to the release of mitogenically active molecules by injured lymphocytes.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1982 by the American Society for Investigative Pathology.